# Retatrutide beats Ozempic on weight loss, blood sugar control, study says

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-29 00:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Intelligence Brief
"Retatrutide beats Ozempic on weight loss, blood sugar control, study says" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by KOMO, BioPharma Dive, PR Newswire and KHOU. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Retatrutide beats Ozempic on weight loss, blood sugar control, study says?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| KOMO | Experimental Lilly drug tops Ozempic in weight loss study | 2026-10-28 17:35 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNZGVWT0hjVUduSHExOUNzYXhlU1hpVXZDcUtOWkJHcGJiMXlIUkNNV0x6RjlJYTBSUi1GMkRFX29UQzNEZU8zcEhLN2JUX3VrZ3FYa2E4QkRLdlN4OWFZVEJtd3NBQ3hUV3FsMUJqQzkzSDY1M1RvdE9rQk51YWNFZHhCYVJpa2d0WTFjRGZ5aHJSYU15WWNiTDAyZk8?oc=5) |
| BioPharma Dive | Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trial | 2026-10-28 17:35 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNN19wd1NRdjNRRTcwb1VndDlmVlNuZGNRMDBpWXV0aXd0UFFkTnZKb1A0dGJCdHZDd1VZN3hsVkFfcXFobTg2TDRyNVZPQ3paWkhRQWdFMHhyczdoaGlFRzhSdXNKU2pYbGcycEFRS08yaHlDZkEyVE5lUFp5RU41TklaTmN1NGFkWWZoNDdHU0EwNm1pbmszTERXUVQ?oc=5) |
| PR Newswire | Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial | 2026-10-28 17:35 | [Source Link](https://news.google.com/rss/articles/CBMipgJBVV95cUxNV1Fpb2ZEcE9hUG5HamR0SklXalI2WUlNT3l6WnNRby1Bc2tJbnlmdFpGUlotM2Y4dy04TlhENjVtZDI1YXkzTzByRmh6TnFjWTdlVC11S1FjcVhmenR1bVR1U0dQV2tTS1V3ZlpyTlVQb0wwOG9ZallmVXhSWng2NmtHdG9KQjY0d0FWc1JrSlM1M3VLZ0xvX2pMajlMRklaTmpYLWp2V0lwdGd4ZGZVamItOVhscDc1SUljcHdzVURvU3JBb2pDSmVUMTR2LVo1S1JPQURtc3FtWThKYTBYUE9XSGV0ZFgzdHJ3R29TbFE0LWRFcDhwS2xhN2tQMjB3REFZZzVEcmhaYTVzY0xHOG13MlFUX1A0bmZvR1RqdzVvX0laMVE?oc=5) |
| KHOU | Eli Lilly says retatrutide shows more weight loss compared to Ozempic | 2026-10-28 17:35 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxPalk1QmJIYS1JUHVpVzBsRlRVeVFZNUFobXpuQXFPWFlkOTBndk1GOERDN3ZsNW1FY29aRDRQRTE2bXg2dUMzOTIya2FrdzlTYlpRVGdZRDExN1FnUWRUMDlTSUFNODhlT1YzTnFqdUFweTBmT2xvRnR5NDJZcDhveldob1BFUGJVVGE5UnJqNkpab2FsTHpWbVRsZjdWcndZWHlfWWxCZzcwVDk4OGVjOUthT0xYQm5OY09sMUl0bUJGaE9PdUctVw?oc=5) |
| WXLV | Experimental Lilly drug tops Ozempic in weight loss study | 2026-10-28 17:35 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQUWI0eDdvYUZCazF1UThyY21ZdGVocTJtRU1QUXFHSERXQ2VxY05rNlo3VHRtaHM5bjAtc2U4U1Zlb2xlbE85M3NTRDQxaVNjZkloVEthQnhCdWstVnNPdjJFcDY5aXoxNjdFT09vanE2R2NsOEk4bW1LTHJnZGQxNm9WUkx3cWhmV1ljcVdkaGhKbkczendfWg?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-29/retatrutide-beats-ozempic-on-weight-loss-blood-sugar-control-study-says*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*